Recombinant Human Interferon-Gamma: Prospects for the Treatment of Chronic Epstein-Barr Viral Infection
Infection of Epstein-Barr virus (EBV) is about 90% among people over the age of 40. The EBV causes a chronic infection that is characterized by chronic or recurrent symptoms and persists for a long time. Recombinant interferon-gamma (IFN-γ) has high clinical and antiviral efficacy in the treatment o...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/79434 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Recombinant Human Interferon-Gamma: Prospects for the Treatment of Chronic Epstein-Barr Viral Infection
- Recombinant Interferon Gamma: Influence on the Cytotoxic Activity of NK Cells in Patients with Chronic Epstein-Barr Virus Infection
- Characteristics of Natural Killers and their Functional Activity in Patients with Chronic Epstein-Barr Virus Infection
- Ocular Manifestations in Epstein Barr Virus Infection
- Lipschütz Ulcer and Epstein-Barr Virus Infection: A Case Report
- Epstein-Barr Virus-Encoded miRNAs in Epstein-Barr Virus-Related Malignancy
- Perspective Chapter: The Role of Interferon Gamma in Clinical Medicine